FORNI, Flavio
 Distribuzione geografica
Continente #
NA - Nord America 21.471
EU - Europa 14.438
AS - Asia 2.896
SA - Sud America 82
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 22
Totale 38.979
Nazione #
US - Stati Uniti d'America 21.388
GB - Regno Unito 5.846
IT - Italia 3.477
SE - Svezia 1.806
CN - Cina 1.067
DE - Germania 872
UA - Ucraina 724
TR - Turchia 719
HK - Hong Kong 687
FI - Finlandia 419
FR - Francia 334
BG - Bulgaria 299
RO - Romania 134
RU - Federazione Russa 104
IN - India 99
IE - Irlanda 82
BE - Belgio 76
NL - Olanda 60
CA - Canada 52
KR - Corea 47
SG - Singapore 42
MY - Malesia 40
CH - Svizzera 39
TH - Thailandia 39
IR - Iran 36
JP - Giappone 32
ES - Italia 29
PL - Polonia 27
BR - Brasile 24
CL - Cile 22
MX - Messico 22
PT - Portogallo 21
VN - Vietnam 21
EU - Europa 20
AU - Australia 17
IL - Israele 17
GR - Grecia 15
CZ - Repubblica Ceca 13
DZ - Algeria 13
MD - Moldavia 13
TW - Taiwan 13
PE - Perù 12
AR - Argentina 9
EG - Egitto 9
AT - Austria 8
CO - Colombia 8
ID - Indonesia 8
DK - Danimarca 7
MA - Marocco 7
SN - Senegal 7
EC - Ecuador 6
HU - Ungheria 6
PK - Pakistan 6
ZA - Sudafrica 6
IQ - Iraq 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
BZ - Belize 4
RS - Serbia 4
SI - Slovenia 4
AL - Albania 3
LT - Lituania 3
NO - Norvegia 3
PH - Filippine 3
SA - Arabia Saudita 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AN - Antille olandesi 2
AZ - Azerbaigian 2
CD - Congo 2
CR - Costa Rica 2
LV - Lettonia 2
NG - Nigeria 2
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
GL - Groenlandia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
VE - Venezuela 1
Totale 38.979
Città #
Southend 5.220
Fairfield 2.615
Chandler 2.171
Woodbridge 1.903
Jacksonville 1.613
Ashburn 1.568
Houston 1.282
Dearborn 1.214
Nyköping 1.060
Seattle 1.050
Ann Arbor 1.049
Wilmington 1.043
Cambridge 871
Hong Kong 675
Modena 471
Izmir 461
Beijing 434
Princeton 324
Sofia 295
Eugene 275
San Diego 233
Des Moines 232
Milan 186
Redwood City 180
Helsinki 161
New York 156
Bremen 145
Rome 134
Fremont 104
London 95
Falls Church 76
Brussels 70
Dublin 66
Boardman 65
Bologna 61
Norwalk 54
Parma 53
Hefei 52
Como 49
Kunming 44
Florence 43
Los Angeles 40
Napoli 39
Shanghai 38
Naples 37
Nanjing 36
Turin 34
Tulare 31
Palermo 29
San Mateo 29
Bari 27
Jinan 26
San Giuliano Milanese 26
Verona 26
Indiana 25
Catania 24
Mountain View 24
Milwaukee 23
Ferrara 22
Guangzhou 22
Auburn Hills 19
Hounslow 19
Augusta 18
Genoa 18
Kocaeli 17
Perugia 17
Philadelphia 17
Toronto 17
Washington 17
Grafing 16
Leawood 16
Kilburn 15
Phoenix 15
Hangzhou 14
Reggio Emilia 14
Saint Petersburg 14
Wuhan 14
Chisinau 13
Dallas 13
Dong Ket 13
Nanchang 13
Tokyo 13
Ardabil 12
Brescia 12
Carmichael 12
Chiswick 12
Fuzhou 12
Halifax 12
Limerick 12
Padova 12
Rende 12
Istanbul 11
Kazan 11
Prescot 11
Salerno 11
Dongguan 10
Mumbai 10
Paris 10
Reggio Nell'emilia 10
Siena 10
Totale 28.955
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 345
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 293
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 289
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 279
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 269
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 268
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 258
Cristallinità ed equivalenza nel cloramfenicolo palmitato 258
NUTRASCIENCE s.r.l. 249
Protein corona and nanoparticles: How can we investigate on? 243
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 236
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 234
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 230
Nanoparticle transport across the blood brain barrier 227
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 224
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 224
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 224
Distribution of drugs in polymers loaded by swelling 223
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 222
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 222
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 219
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 217
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 217
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 213
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 209
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 208
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 206
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 206
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 203
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 199
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 199
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 198
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 197
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 195
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 193
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 192
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 191
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 191
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 190
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 186
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 185
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 185
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 185
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 184
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 184
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 182
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 181
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 180
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 180
Colloidal systems for CNS drug delivery 179
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 179
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 179
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 178
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 178
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 177
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 177
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 177
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 177
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 176
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 176
EFFECT OF MONTMORILLONITE ON DRUG RELEASE FROM POLYMERIC MATRICES 175
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 175
Proprietà fisiche e disponibilità del cloramfenicolo palmitato in miscele macinate con cellulosa microcristallina 175
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 175
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 174
Functionalization of liposomes: microscopical methods for preformulative screening 174
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 174
Effect of the loading method on the drug release from cross-linked carboxymethylcellulose beads 174
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 172
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 172
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 172
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 172
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 169
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 168
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 167
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 167
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 167
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 166
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 165
Solfadiazina: microincapsulazione e studio del rilascio 164
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 164
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 164
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 164
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 164
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 163
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 162
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 162
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 162
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 161
Polymeric nanoparticles for the drug delivery to the central nervous system 160
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 158
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 158
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 157
Ketorolac tromethamine liposomes: Encapsulation and release studies 156
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 156
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 155
Nanomedicine and neurodegenerative disorders: So close yet so far 154
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 154
An interpretation of the diffusion-type mechanism of drug release from microcapsules 150
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 150
Totale 19.236
Categoria #
all - tutte 131.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.909 0 0 0 0 0 0 0 0 0 0 949 960
2019/20208.305 498 465 281 475 990 1.088 1.413 922 927 334 532 380
2020/20217.376 1.077 297 521 661 712 432 629 867 320 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.407 185 227 226 295 816 391 468 527 138 118 16 0
Totale 39.420